| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 14, 2026 | Tandem Health scores $100M Series B, led by EU’s €5bn tech startup fund | Swedish healthtech startup Tandem Health has raised $100m in a Series B funding round, which was led by the EU-backed €5bn Scaleup Europe Fund, a new investor. The round, which is large for a Series B, also features existing investors Kinne... |
| Sep 14, 2026 | Startup Funding News Today, September 14, 2026: Chift, Qupital, Tandem Health, Fortaegis & More | Startup funding opened the week with a surprisingly coherent message: investors are backing AI where it sits inside hard financial, clinical, security, and data infrastructure rather than financing another wave of generic model wrappers.
Ho... |
| Sep 14, 2026 | Tandem Health capta 100 millones de dólares en una ronda liderada por el Scaleup Europe Fund | Tandem Health, la empresa de healthtech que está llevando la sanidad europea a la era de la IA, ha anunciado hoy que ha captado 100 millones de dólares en una ronda Serie B liderada por el Scaleup Europe Fund, gestionado por EQT, con el apo... |
| Sep 14, 2026 | Шведский стартап превратит ИИ-ассистента в операционную систему для европейских клиник | Стокгольмский медицинский стартап Tandem Health привлек €86,5 млн ($100 млн) в раунде серии B. Компания развивает ИИ-платформу, которая берет на себя часть административной работы врачей, а в перспективе должна превратиться в полноценную оп... |
| Apr 24, 2026 | Calibre: $3.3 Million Raised To Launch Proactive Health Intelligence Platform | Calibre has officially launched alongside a $3.3 million pre-seed funding round, aiming to redefine how individuals understand and manage their health. The company is focused on eliminating what it describes as “health guesswork” by deliver... |
| Apr 22, 2026 | Calibre emerges from stealth with $3.3M to tackle “health guesswork” through causal AI | Calibre, a London-based Healthtech company, launches out of stealth today to introduce a new category in proactive health: Causal Health Navigation.
Calibre combines clinical expertise with causal AI to help people understand what is actual... |
| Apr 22, 2026 | Modern Relay: $3 Million Seed Funding Raised To Build AI-Native Knowledge Infrastructure | Modern Relay announced it has emerged from stealth with $3 million in funding to build a new platform designed to structure and govern organizational knowledge in the age of AI agents. The round was backed by Point Nine, Emerge VC, Amino Co... |
| Apr 19, 2026 | Modern Relay Secures $3M to Unify Enterprise AI Operations | Modern Relay, an AI infrastructure innovator, recently closed a $3 million funding round. This capital infusion will accelerate the development of a critical shared operational layer for enterprise AI agents. Organizations grapple with frag... |
| Apr 16, 2026 | Modern Relay Raises $3M in Funding | Modern Relay, a Barcelona, Spain- and San Francisco, CA-based Ai company company that is advancing an operational infrastructure for AI agents to work inside enterprises, raised $3m in funding.
Backers included Point Nine, Emerge, Amino Col... |
| Apr 14, 2026 | Modern Relay raises $3M to build shared infrastructure layer for AI agents in the enterprise | Modern Relay today announced a $3 million funding round from Point Nine, Emerge, Amino Collective, Common Magic, and angels, including Charlie Songhurst (board member at Meta), Michael Boehler (former BioNTech executive), and Thomas Clozel ... |
| Mar 24, 2026 | Dash0 erhält 110 Millionen – Rivia bekommt 15 Millionen – Amazon übernimmt RIVR | Im #DealMonitor für den 24. März werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc... |
| Mar 19, 2026 | AI Engine Transforms Clinical Trials: Rivia Secures $15M to Revolutionize Drug Development | Rivia secured $15M Series A funding. The company tackles fragmented clinical trial infrastructure. It introduces an AI-driven data engine. This engine unifies vast, disparate trial data. It replaces costly, manual reconciliation. Spreadshee... |
| Mar 19, 2026 | Rivia Secures $15M to Propel AI-Powered Clinical Trials into New Era | Zurich-based Rivia secured $15 million in Series A funding. This investment propels its AI-driven platform. Rivia tackles clinical trial complexity. Its agentic data engine unifies vast data. It streamlines operations. The company aims to c... |
| Mar 19, 2026 | Rivia: $15 Million Series A Raised By Clinical Trial Data Infrastructure Company | Rivia, a Zurich-based software development company focused on AI-driven clinical trial data infrastructure, has raised an oversubscribed $15 million Series A funding round, according to an announcement shared on the company’s LinkedIn page.... |
| Mar 18, 2026 | Rivia raises $15M to fix the broken data infrastructure behind clinical trials | Rivia, the Zurich-based data engine for clinical trial intelligence, today announced a $15 million Series A led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino Collective, and Nina Capital.
Over the p... |
| Mar 18, 2026 | Rivia raises $15M Series A to bring clinical trials into the agentic AI era |
Clinical trials have become exponentially more complex. Data volume has increased more than 400 percent over the past decade. Biotech and Pharma operators still rely on fragmented spreadsheets and rigid legacy systems. Thousands of human h... |
| Mar 18, 2026 | Rivia Raises $15M in Series A Funding | Rivia, a Zurich, Switzerland-based provider of a clinical trial data engine and AI platform, raised $15m in Series A funding.
The round was led by Earlybird, with participation from Defiant, Speedinvest, Amino Collective, and Nina Capital.
... |
| Mar 18, 2026 | Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine | Rivia, a Zurich-based startup specialising in AI-driven analytics and clinical trial data infrastructure for BioTechs, today announced a €13 million ($15 million) Series A to accelerate team growth, scale agentic product development, and ex... |
| Dec 17, 2025 | Valinor: $13 Million Seed Funding Raised To Boost Clinical Trial Success With Multimodal Machine Learning | Valinor, a San Francisco-based AI company focused on improving clinical trial outcomes through machine-learning-driven patient response prediction, announced $13 million in seed funding to scale its multimodal platform for patient selection... |
| Dec 16, 2025 | Valinor Secures $13 Million to Revolutionize Clinical Trials with AI | Valinor, a San Francisco-based AI firm, just raised $13 million. This seed funding aims to improve clinical trial success. The company uses machine learning. It analyzes patient data to predict treatment response. This reduces trial failure... |
| Dec 16, 2025 | AI Firm Valinor Secures $13M to Revolutionize Clinical Trials | Valinor, a San Francisco-based AI company, just raised $13 million in seed funding. The company aims to drastically improve clinical trial success rates. It uses AI to predict patient response to drugs *before* trials begin. This “response-... |
| Dec 13, 2025 | Valinor Raises $13 Million To Advance AI-Driven Patient Selection For Clinical Trials | Valinor, a San Francisco-based artificial intelligence company focused on improving clinical trial outcomes, has raised $13 million in seed funding to expand its proprietary machine learning platform for patient selection. The financing was... |
| Dec 12, 2025 | Valinor Raises $13M in Funding | Valinor, a San Francisco, CA-based AI company leveraging machine learning models to increase the probability of clinical trial success, raised $13M in Seed funding.
The round was led by CRV, Harpoon Ventures, Amino Collective, and Pelion Ve... |
| Dec 11, 2025 | Valinor Raises $13M to Predict Clinical Trial Outcomes Using Multi-Omic AI | What You Should Know:
– Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry’s most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
– The company uses proprietary AI model... |
| Jul 14, 2025 | Tandem Health raises $50M Series A to scale its AI scribe across the NHS | Stockholm healthtech Tandem Health has raised $50 million Series A funding and has pledged that a “significant proportion” of the funds will be used to drive AI innovation within the NHS. The raise brings the company’s funding to over $109 ... |
| Jul 1, 2025 | Tandem Health: A Breath of Fresh Air for Overburdened Clinicians | In the bustling world of healthcare, where every second counts, Tandem Health emerges as a beacon of hope. This Stockholm-based startup has recently secured $50 million in Series A funding, a significant leap toward reshaping the administra... |
| Jun 30, 2025 | Swedish startup Tandem Health secures €42.6 million to reduce admin burden on clinicians | Stockholm-based Tandem Health, a HealthTech startup transforming how clinicians manage administrative tasks through AI-powered documentation, has announced a €42.6 million Series A funding round to accelerate its product development and exp... |
| May 12, 2025 | Inductive Bio: Pioneering the Future of Drug Discovery with $25 Million Series A Funding | In the bustling heart of New York City, a quiet revolution is brewing. Inductive Bio, a trailblazer in artificial intelligence (AI) for small molecule drug discovery, has secured $25 million in Series A funding. This financial boost, led by... |
| May 11, 2025 | Inductive Bio: $25 Million Series A Closed To Transform Small Molecule Drug Discovery | Inductive Bio, a company democratizing AI models to transform small molecule drug discovery, announced that it has raised $25 million in Series A funding led by Obvious Ventures with participation from Andreessen Horowitz (a16z) Bio + Healt... |
| Apr 11, 2025 | REMATIQ raises €5.4 million to transform MedTech compliance with AI | Berlin-based REMATIQ, an AI-native platform for automated product compliance in MedTech, has raised €5.4 million in a Seed funding round to develop its AI technology, expand its engineering team, and drive growth across Europe and the U.S.
... |
| Mar 13, 2025 | Junction Secures $18M to Revolutionize Healthcare Infrastructure | In a world where healthcare is often a tangled web of outdated systems, Junction is stepping in with a fresh approach. The company recently announced an impressive $18 million Series A funding round, led by Creandum, with support from notab... |
| Mar 11, 2025 | Junction Raises $18M for Modern Healthcare Infrastructure | What You Should Know:
– Junction, a pioneering healthcare infrastructure company raises $18M in Series A funding round ed by Creandum, with participation from Y Combinator, Point Nine, Amino Collective, and Inflect Health.
– The investment ... |
| Mar 11, 2025 | Junction Raises $18M Series A to build better healthcare infrastructure that improves patient experience | New York, United States, March 11th, 2025, FinanceWire
Junction, a healthcare infrastructure company, has announced an $18 million Series A funding round led by Creandum, with participation from Y Combinator, Point Nine, Amino Collective, a... |
| Jun 12, 2024 | €3M to bring AI analytics and advanced data infrastructure to clinical trials |
Founded by seasoned biopharma experts familiar with the industry's pain points, Rivia focuses on creating user-friendly software tailored to the needs of biotech firms. Rivia addresses a significant inefficiency in the industry: current da... |
| Oct 26, 2022 | Seqera Labs raises €22 million in Series A funding led by Addition. Participates Speedinvest, Talis, BoxOne and Amino | 25/10/2022
Nota de prensa
SEQERA LABS RAISES €22 MILLION IN SERIES A FUNDING LED BY ADDITION
Today, Seqera Labs, the leading provider of data orchestration and workflow software for life sciences, announced that it has raised €22 million... |
| Oct 24, 2022 | Former Tiger Global partner Lee Fixel’s Addition leads Seqera Labs’ €22 million investment round | Used by AstraZeneca, Janssen Pharmaceuticals, Oxford Nanopore, and over 150 leading pharmaceutical and biotechnology companies, and a driving force behind the fight against Covid-19, Barcelona-based Seqera Labs has raised €22 million in a S... |
| Oct 24, 2022 | Addition leads Seqera Labs’ €22 million investment round | Used by AstraZeneca, Janssen Pharmaceuticals, Oxford Nanopore, and over 150 leading pharmaceutical and biotechnology companies, and a driving force behind the fight against Covid-19, Barcelona-based Seqera Labs has raised €22 million in a S... |
| Sep 21, 2022 | Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies | Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies
Wed, Sep 21, 2022 09:00 CET Report this content
Liquid biopsy cancer testing is one of the most transformational innovations in healthcare for the... |
| Jun 3, 2022 | Breaking down the silos of wearables Vital checks stats with $2.9 million | I’m going to guess that the Apple Watch, the Fitbit, the Garmin, or any number of other wearable health monitoring devices are within your reach right now.
Let’s admit it: we all like to see some progress in our health, and, between you and... |
| Mar 15, 2022 | Equipped with $12 million and digital therapeutics, Vira Health plans to take on older women’s health | As companies redefine their benefits more broadly in recognition of mental health and caring responsibilities that resulted from COVID-19, menopause is becoming a bigger part of the conversation. A study by Vodafone across five countries fo... |
| Feb 4, 2022 | What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis | Berlin-based AI driven genetic analysis platform Nostos Genomics has raised a €5 million seed funding from 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. Other investors in the round included Konstantin Mehl (Kaia Healt... |
| What does your genetic data tell about you? Berlin’s Nostos Genomics raises €5 million to speed up disease diagnosis | Berlin-based AI driven genetic analysis platform Nostos Genomics has raised a €5 million seed funding from 42CAP, Frontline Ventures, Amino Collective and Entrepreneur First. Other investors in the round included Konstantin Mehl (Kaia Healt... |
| Breaking down the silos of wearables Vital checks stats with $2.9 million | I’m going to guess that the Apple Watch, the Fitbit, the Garmin, or any number of other wearable health monitoring devices are within your reach right now.
Let’s admit it: we all like to see some progress in our health, and, between you and... |
| Equipped with $12 million and digital therapeutics, Vira Health plans to take on older women’s health | As companies redefine their benefits more broadly in recognition of mental health and caring responsibilities that resulted from COVID-19, menopause is becoming a bigger part of the conversation. A study by Vodafone across five countries fo... |
